These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36254738)

  • 1. Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular Events.
    Buckley LF; Baker WL; Van Tassell BW; Cohen JB; Alkhezi O; Bress AP; Dixon DL
    Hypertension; 2023 Feb; 80(2):305-313. PubMed ID: 36254738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic and diastolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension and pre-frailty or frailty status.
    Zhu J; Yang K; Liu W
    J Clin Hypertens (Greenwich); 2024 May; 26(5):514-524. PubMed ID: 38552135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of long-term time in target range for systolic blood pressure with cardiovascular risk in the elderly: a Chinese veteran cohort study.
    Lin Z; Xiao Z; Chen W; Xu W; Huang C; Xie J; Jin M; Wei X; He S; Xie Z; Liao W; Liao Y; Feng W; Chen Y; Bin J
    Eur J Prev Cardiol; 2023 Aug; 30(10):969-977. PubMed ID: 36947144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic Blood Pressure Time in Target Range and Incident Atrial Fibrillation in Patients With Hypertension: Insights From the SPRINT Trial.
    Wang J; Jiang C; Li S; Wang Z; Wang Y; Lai Y; Wang Z; Lv W; Bai Y; Yang Z; Guo Q; Huang L; He L; Guo X; Li S; Liu N; Jiang C; Tang R; Long D; Du X; Sang C; Dong J; Ma C
    Hypertension; 2023 Nov; 80(11):2306-2314. PubMed ID: 37589154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study.
    Feng Z; Li Y; Wang C; Tian L; Yao S; Wang M; Zhao M; Lan L; Wu S; Xue H
    J Clin Hypertens (Greenwich); 2024 Jun; 26(6):714-723. PubMed ID: 38651799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic Blood Pressure Time in Target Range and Cognitive Outcomes: Insights From the SPRINT MIND Trial.
    Li S; Jiang C; Wang Y; Lai Y; Zhao M; Li Q; Bai Y; Dai W; Guo Q; He L; Guo X; Wang W; Li S; Liu N; Jiang C; Tang R; Sang C; Long D; Du X; Dong J; Anderson CS; Ma C
    Hypertension; 2023 Aug; 80(8):1628-1636. PubMed ID: 37165869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood pressure targets in adults with hypertension.
    Arguedas JA; Leiva V; Wright JM
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD004349. PubMed ID: 33332584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Risk Reduction After Renal Denervation According to Time in Therapeutic Systolic Blood Pressure Range.
    Mahfoud F; Mancia G; Schmieder RE; Ruilope L; Narkiewicz K; Schlaich M; Williams B; Ribichini F; Weil J; Kao HL; Rodriguez-Leor O; Noory E; Ong TK; Unterseeh T; de Araújo Gonçalves P; Zirlik A; Almerri K; Sharif F; Lauder L; Wanten M; Fahy M; Böhm M
    J Am Coll Cardiol; 2022 Nov; 80(20):1871-1880. PubMed ID: 36357087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home systolic blood pressure time in therapeutic range and cardiovascular risk: the practitioner-based nationwide J-HOP study extended.
    Kario K; Tomitani N; Okawara Y; Kanegae H; Hoshide S
    Hypertens Res; 2024 Jan; 47(1):112-119. PubMed ID: 37714954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
    Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
    JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Intensive Systolic Blood Pressure Lowering on End-Stage Kidney Disease and Kidney Function Decline in Adults With Type 2 Diabetes Mellitus and Cardiovascular Risk Factors: A Post Hoc Analysis of ACCORD-BP and SPRINT.
    Tawfik YMK; Van Tassell BW; Dixon DL; Baker WL; Fanikos J; Buckley LF
    Diabetes Care; 2023 Apr; 46(4):868-873. PubMed ID: 36787937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Acute Kidney Injury with Cardiovascular Events and Death in Systolic Blood Pressure Intervention Trial.
    Dieter BP; Daratha KB; McPherson SM; Short R; Alicic RZ; Tuttle KR
    Am J Nephrol; 2019; 49(5):359-367. PubMed ID: 30939480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study.
    Rodriguez CJ; Swett K; Agarwal SK; Folsom AR; Fox ER; Loehr LR; Ni H; Rosamond WD; Chang PP
    JAMA Intern Med; 2014 Aug; 174(8):1252-61. PubMed ID: 24935209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Findings from the KNOW-CKD Study indicate that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression.
    Park CH; Kim HW; Joo YS; Park JT; Chang TI; Yoo TH; Park SK; Kim YH; Sung S; Hyun YY; Oh KH; Kang SW; Han SH;
    Kidney Int; 2024 Apr; 105(4):835-843. PubMed ID: 38159679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.
    Navar AM; Gallup DS; Lokhnygina Y; Green JB; McGuire DK; Armstrong PW; Buse JB; Engel SS; Lachin JM; Standl E; Van de Werf F; Holman RR; Peterson ED;
    Hypertension; 2017 Nov; 70(5):907-914. PubMed ID: 28847886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
    Xie X; Atkins E; Lv J; Bennett A; Neal B; Ninomiya T; Woodward M; MacMahon S; Turnbull F; Hillis GS; Chalmers J; Mant J; Salam A; Rahimi K; Perkovic V; Rodgers A
    Lancet; 2016 Jan; 387(10017):435-43. PubMed ID: 26559744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Risk of Harm Associated With Intensive Blood Pressure Management Among Patients With Hypertension Who Smoke: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial.
    Scarpa J; Bruzelius E; Doupe P; Le M; Faghmous J; Baum A
    JAMA Netw Open; 2019 Mar; 2(3):e190005. PubMed ID: 30848803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of baseline systolic blood pressure on the relationship between intensive blood pressure control and cardiovascular outcomes in the Systolic Blood Pressure Intervention Trial (SPRINT).
    Sun X; Guo Y; Nie Z; Cheng J; Zhou H; Zhong X; Zhang S; Du Z; Zhuang X; Liao X
    Clin Res Cardiol; 2019 Mar; 108(3):273-281. PubMed ID: 30167807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.